Improving collaboration in osteoporosis treatment after hip fractures
Collaboration to Improve Bone Health
This study is testing if better teamwork between doctors can help older patients who have had a hip fracture get the right osteoporosis treatment to prevent more fractures.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 200 (estimated) |
| Ages | 75 Years and up |
| Sex | All |
| Sponsor | University Hospital, Akershus Academic / other |
| Locations | 1 site (Lørenskog, Akershus) |
| Trial ID | NCT05904353 on ClinicalTrials.gov |
What this trial studies
This study aims to enhance the cooperation between primary and secondary healthcare providers in treating osteoporosis following a hip fracture in patients aged 75 and older. Participants will receive an infusion of zoledronic acid, along with vitamin D and calcium supplements, to prevent further fractures. General practitioners will be involved in the follow-up care, administering annual infusions of zoledronic acid for three years after the initial treatment. The goal is to ensure that patients continue receiving necessary treatments after hospital discharge.
Who should consider this trial
Good fit: Ideal candidates for this study are patients aged 75 years or older who have experienced a hip fracture.
Not a fit: Patients who refuse treatment, have other osteoporosis treatments indicated, or have dementia may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly reduce the incidence of new fractures in elderly patients by ensuring consistent osteoporosis treatment.
How similar studies have performed: While similar collaborative approaches have been explored, this specific intervention focusing on post-hip fracture osteoporosis treatment is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients 75 years or older with a hip fracture Exclusion Criteria: * Refuse treatment * Another treatment of osteoporosis is indicated * Guest patient, do not live in the admission area * Dementia
Where this trial is running
Lørenskog, Akershus
- Orthopedic Department, Akershus University Hospital — Lørenskog, Akershus, Norway (Recruiting)
Study contacts
- Principal investigator: Jakob Vangen Nordbø, MD — University Hospital, Akershus
- Study coordinator: Jakob Vangen Nordbø, MD
- Email: Jakob.Vangen.Nordbo@ahus.no
- Phone: +4797124493
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.